14:30 – 14:40 Welcome and introduction – Silvio Inzucchi, Stefan Anker
14:40 – 14:50 Cardiovascular mortality in T2D: old challenges, new opportunities – All faculty, moderated by Silvio Inzucchi
14:50 – 15:10 Optimising T2D management: what’s driving treatment decision? – Silvio Inzucchi
15:10 – 15:35 Advancing patient care in T2D: what does the emerging evidence tell us? – Mikhail Kosiborod
15:35 – 16:15 Exploring the effects of SGLT2 inhibition in ongoing clinical trials – Stefan Anker, Merlin Thomas
16:15 – 16:25 Rethinking treatment decisions to optimise patient outcomes – Panel discussion and audience Q&A; All faculty, moderated by Silvio Inzucchi
16:25 – 16:30 Chair’s summary – Silvio Inzucchi
Todos os direitos reservados